Celldex Therapeutics, Inc. (NASDAQ:CLDX) Strong Technical chart that is flagging. If volume comes back in, the stock will run again. ( click to enlarge )
Gevo, Inc. (NASDAQ:GEVO) is looking to get back over its 50-day moving average. The news out today after the bell may bring the volume to get it there. Bloomberg : Gevo Wins Ruling for No Infringement of Butamax Patent . I am going to watch the action tomorrow since the short float is more than 35% !! I think it's a short-squeeze candidate. Keep on watch tomorrow. ( click to enlarge ) Research In Motion Ltd (NASDAQ:BBRY) The technical chart continue to show a bullish bias. The MACD line is pointing up. RSI is also increasing and is now above the 50% level. +DI is above –DI . Additionally, in the daily stock is forming a flag pattern. This pattern is a bullish one so a rally could happen. Let's see if the stock price will confirm it. ( click to enlarge ) Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) edged higher on stronger than usual volume. The stock price closed above the 20-day moving average of $6.25. As long as prices remain above the moving average key indicator, traders will view this development as a sign of strength. Based on the pivot points the current support and resistance levels for ACAD are $5.99 and $6.88 ( click to enlarge ) Platinum Group Metals Limited (USA) (NYSEAMEX:PLG) Breakout watch at 1.52 During the day I tweet many times to my readers. I encourage everybody to subscribe AC Investor Blog twitter and newsletter, so you can receive my trade ideas and stock news in real time. Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence. Thanks for visiting AC Investor Blog.